Gin S. Malhi, MD

  • 13Articles
  • 66.2KReads
  • 2001–2025Active
  • 65Collaborators
  • 465Citations

About

Gin S. Malhi, MD, is affiliated with the Academic Department of Psychiatry at the Kolling Institute and Northern Clinical School, The University of Sydney, as well as the CADE Clinic and Mood-T at Royal North Shore Hospital in Australia, and the Department of Psychiatry and Oxford Uehiro Centre for Practical Ethics at the University of Oxford, UK. Malhi has published extensively on topics including major depressive disorder, bipolar disorder, schizophrenia and schizoaffective disorders, obsessive-compulsive and related disorders, suicide, violence, and aggression. The author’s work addresses clinical and pharmacological aspects of these conditions, including lithium therapy, adjunctive treatments such as N-acetylcysteine, and the impact of substance use on psychosis. Malhi’s research also explores methodological issues in psychiatric trials and the conceptualization of psychiatric diagnoses and symptoms.

Publications

JCP
What Is Meant by the Term “Deprescribing,” and Does It Belong in Our Lexicon?
JCP
Erecting Barriers to Suicide by Removing Barriers to Science
JCP
A New Tool to Refine Lithium Therapy: Simple Formula for a Complex Problem
JCP
JCP
JCP
JCP
JCP
JCP
JCP
JCP
JCP

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.